United States General Surgical Devices Market Size

US General Surgical Devices Market Analysis

The United States General Surgical Devices Market is expected to register a CAGR of 6.1% during the forecast period.

The COVID-19 pandemic significantly impacted surgical practice ranging from workforce and staff shortage, procedural prioritization, viral transmission risk, changes to perioperative practice, and ways of working alongside the impact on surgical education and training. The volume of surgeries significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. According to a research article published in Jama Network in December 2021, a 48.0% decrease in total surgical procedure volume was reported immediately after the March 2020 recommendation to cancel elective surgical procedures. Furthermore, according to another article published in the Journal of Surgical Research in June 2021, there was a 91% reduction from baseline in the number of elective surgeries performed, allowing 78% of surgical ICU beds to be available for COVID-19 patients. Thus, the United States general surgical devices market has been significantly impacted by COVID-19.

Factors like the increasing demand for minimally invasive devices and the growing cases of injuries and accidents are propelling the market growth. Minimally invasive surgeries (MIS) cause less post-operative pain, and hence, patients receive smaller dosages of painkillers. As minimal cuts or stitches are involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. An increasing number of product launches for minimally invasive surgeries are anticipated to drive the market's growth. For instance, in September 2021, Medtronic PLC launched a minimally invasive spine surgery ecosystem to combine spinal implants, biologics, navigation, robotics, and AI-powered data for surgeons and patients. This included Catalyft PL and PL40, Space-D Access System, and Accelerate Graft Delivery System with Grafton DBF. The benefits of minimally invasive surgeries create high demand for these devices.

Moreover, the increased prevalence of chronic diseases has also promoted the demand for surgical devices in various surgeries, such as cardiovascular, orthopedic, and plastic surgeries, driving the market growth. According to the article "Trauma of Major Surgery" published in the NCBI in July 2020, around 40 to 50 million major surgeries were performed annually in the United States. Thus, increasing surgeries are also anticipated to drive the market's growth.

Thus, the increasing demand for minimally invasive surgical devices and the rising burden of chronic diseases will likely drive the market growth.